Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 524

Although the interplay between sex and mental health is well-studied, a new study suggests there may be a complex correlation between seemingly disparate disorders.

In a new paper published in the Journal of Affective Disorders Reports, a group of Italian psychology researchers say they’ve found a correlation between attention-deficit/hyperactivity disorder (ADHD), depressive symptoms, hypomania (the clinical term for “mania” or high energy) and hypersexuality, or an intense preoccupation with sexual thoughts and acts — and that people who experience these sets of symptoms may use sex as a sort of “self-medication.”

Study coauthors Giacomo Ciocca, a sexual psychology assistant professor at Rome’s Sapienza University, and Davide Doroldi, a clinical psychologist, told PsyPost that they were inspired to look into the possible link after observing higher rates of hypersexuality among people with ADHD.

Read more | >

The capacity of intestinal stem cells to maintain cellular balance in the gut decreases upon ageing. Researchers at the University of Helsinki have discovered a new mechanism of action between the nutrient adaptation of intestinal stem cells and ageing. The finding may make a difference when seeking ways to maintain the functional capacity of the ageing gut.

The cellular balance of the intestine is carefully regulated, and it is influenced, among other things, by nutrition: ample nutrition increases the total number of cells in the gut, whereas fasting decreases their number.

The relative number of different types of cells also changes according to nutrient status.

Read more | >

The Expedition 66 crew continued preparing today for the first of two spacewalks set to begin next week to continue upgrading the International Space Station’s power system. Vein scans were also on Thursday’s schedule helping scientists understand how living in space affects the human body.

NASA Flight Engineers Kayla Barron and Raja Chari are set to switch their U.S. spacesuits to battery power at 8:05 a.m. EDT on Tuesday and spend six-and-a-half hours installing a modification kit on the space station’s Starboard-4 truss structure. The new hardware will enable the upcoming installation of a third roll-out solar array increasing the station’s power output and augmenting the existing solar arrays.

The duo was joined by fellow station astronauts Tom Marshburn of NASA and Matthias Maurer of ESA (European Space Agency) for a spacewalk procedures review and conference with specialists on the ground. Marshburn and Maurer will assist the spacewalkers in and out of their spacesuits, operate the Canadarm2 robotic arm, and monitor their external activities. Mission managers will talk about the spacewalk, as well as a second one planned for March 23, live on the NASA TV app and the website on Monday at 2 p.m. NASA TV begins its live spacewalk broadcast on Tuesday at 6:30 a.m.

Read more | >

A team of Rutgers undergraduates has shown that an experimental drug known as Yoda1 may help drain cranial waste plus neurotoxins that cause Alzheimer’s disease and other forms of dementia.

Rutgers study led by undergrads and gap-year students breaks ground in the field of neuroscience and suggests experimental medication could treat dementia.

Read more | >

“This trial has changed the lives of people with mesothelioma, allowing us to live longer,” said one of the patients who benefited from the drug. The 80-year-old, who wished to remain anonymous, won compensation from his former employer after being exposed to asbestos in a factory in the 1970s.

He was given four months to live, but thanks to the trial is still alive five years later. “I have five grandchildren and two great-grandchildren now – I wouldn’t want to miss all that,” he said.

The breakthrough is significant, experts say, because mesothelioma has one of the lowest survival rates of any cancer. The new drug, ADI-PEG20 (pegargiminase), is the first of its kind to be successfully combined with chemotherapy in 20 years.

Read more | >

Groundbreaking research led by a global group of over 100 researchers will enable a more in-depth exploration of human genetic variation as fully sequencing the Y chromosome, a feat that has challenged scientists for years, has been accomplished for the first time. In this interview, we speak to Dylan Taylor about this impactful research and how it may shape our understanding of human genetics.

Please could you introduce yourself and your current research activities?

I am Dylan Taylor, a Ph.D. candidate and NIH F31 fellow in the Department of Biology at Johns Hopkins University. My work with the T2T consortium focuses on exploring how a complete reference genome can improve our ability to study human genetic variation and how it impacts human traits and health.

Read more | >

Polyploidization-rediploidization process plays an important role in plant adaptive evolution. Here, the authors assemble the genomes of mangrove species Sonneratia alba and its inland relative Lagerstroemia speciosa, and reveal genomic evidence for rediploidization and adaptive evolution after the whole-genome triplication.

Read more | >

I have written a lot about vaccines that treat cancer. Now we have another new mRNA vaccine to treat pancreatic cancer that has shown promising results in phase 1 clinical trials and is now entering a larger phase 2 clinical trial. This is exciting news for a deadly cancer that attacks tens of thousands of people each year.

The mRNA vaccine technology is going to be one of the leading technologies for cancer treatments going forward. If it can make a meaningful dent in the course of pancreatic cancer, it may well become one of the primary tools for oncologists in treating this pernicious disease.

As I usually do, let’s review this vaccine and the clinical trial results.

Read more | >